Vascular-type Ehlers-Danlos syndrome (EDS) is a rare inherited connective tissue disorder caused by a mutation in type III procollagen. It has the highest mortality rate among the six types of EDS. Patients with this syndrome often have typical medical histories and a characteristic physical examination. We present two patients with this rare disorder and highlight the diagnostic and treatment challenges. N ear the turn of the 20th century, Drs. Ehlers and Danlos described individuals with increased skin elasticity, hyperextensible joints, susceptibility to ecchymoses, and cutaneous lesions ( 1 ) . Th is description, combined with the initial cases presented by Russian dermatologist Dr. Tschernogobow at the Moscow Venereology and Dermatology Society conference in 1892, added validity to the concept, and wide acceptance of Ehlers-Danlos syndrome (EDS) was garnered by 1936 ( 2 ) . Six diff erent subtypes of EDS have been described by the Villefranche classifi cation schematic ( 3 ). Vascular-type EDS (EDS type 4), a rare inherited connective tissue disorder caused by a mutation in type III procollagen ( Col3A1 ), has the highest mortality rate of the six types of EDS ( 3 ) . It has an autosomal dominant transmission with 100% penetrance and comprises 5% to 10% of all cases of EDS. Vascular-type EDS is often characterized by major and minor criteria including vascular rupture or dissection, narrow facies, hyperpigmentation, pale skin with visible subcutaneous vessels, and easy bruisability. Fatal complications such as arterial dissections, digestive tract rupture, and other organ rupture can occur in up to 80% of aff ected individuals before the age of 40. Th e syndrome is linked with genetic abnormalities in types I, III, or V collagen critical to extracellular matrix formation. We present two cases of vascular-type EDS that highlight the diagnostic and treatment challenges encountered with these patients.
PATIENT 1
A 31-year-old man presented with sudden-onset, bilateral upper abdomen pain and several bouts of bilious emesis. His past medical history was notable for bilateral inguinal herniorrhaphies and bilateral shoulder dislocations in high school. His family history was negative. On admission, he had a fever of 101.5°F but was hemodynamically stable. His physical examination was remarkable for pale skin, periorbital hyperpigmentation, talipes 
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Jocelyn Carter, MD, MPH, and Andrew Z. Fenves, MD equinovarus, and exaggerated joint laxity. His laboratory studies were notable only for a leukocytosis. A computed tomography (CT) scan of the abdomen and pelvis demonstrated a left common and external iliac dissection (with evidence of prior extravasation without active leak) as well as bilateral renal infarcts, a small left common iliac aneurysm (1.7 cm), and a question of bilateral renal artery aneurysms. A renal artery duplex study was inconclusive regarding the presence of renal artery aneurysms, and a renal angiogram was ordered. A CT scan of the head, neck, and chest showed no additional signifi cant vascular changes. Concerns for a connective tissue disease or a genetic syndrome prompted rheumatology and genetics consults. Th e genetics team suggested vascular-type EDS as the most likely diagnosis. Th e renal angiogram was then cancelled due to the potential risk of renal dissection or obliteration. Rheumatological markers and hypercoagulability testing all returned negative. An angiotensinconverting enzyme inhibitor was started as standard therapy. Genetic testing later confi rmed a diagnosis of vascular-type EDS with a Gly981Arg mutation.
PATIENT 2
A 69-year-old man presented to the hospital with urinary frequency. He developed pelvic discomfort, and a subsequent CT with intravenous contrast revealed a 6 × 6 mm renal stone at the right ureterovesicular junction with right-sided hydronephrosis. Important incidental fi ndings on this scan were bilateral iliac aneurysms and focal dissections and pseudoaneurysms of the celiac, distal mesenteric, left gastric, superior mesenteric, and superior left renal arteries. Th e patient's past medical history included the presence of hypertension, previous kidney stones, and two previous cerebrovascular accidents. A recent admission for a transient ischemic attack prompted a cerebral contrast CT angiogram showing large aneurysms with a clot at the base of the right vertebral artery and an arteriovenous shunt in the distal right vertebral artery segment. Th e patient also had a history of inguinal and ventral hernia repairs. Th e patient's family history was notable for a brother who had an unexplained spontaneous bowel rupture requiring urgent surgical repair at age 60. His physical examination was notable for decreased strength in the right upper and lower extremities. A renal angiogram was scheduled to further evaluate the renal vasculature.
After an extensive negative rheumatologic evaluation, vascular surgery, rheumatology, and the genetics services suggested a diagnosis of vascular-type EDH, despite the lack of classical skin fi ndings or facial appearance. Accordingly, vascular surgery cancelled the patient's renal artery angiogram in fear of a high risk for potential arterial dissection. Th e patient subsequently had a genetic analysis in the 12 genes known to be associated with genetic forms of thoracic aortic aneurysms, including vascular-type EDS, Marfan syndrome, and related disorders. Th is panel was negative in this patient. However, given possible variations in disease-associated mutations, additional genetics testing was pursued. Deletion or duplication of one or more of the 12 exons in the thoracic aortic aneurysms and dissections panel was suspected, and the diagnosis of vascular-type EDS was maintained. Treatment with daily aspirin, losartan, simvastatin, and amlodipine was initiated.
DISCUSSION
In vascular-type EDS, vascular dissection or organ rupture may occur in the thorax and abdomen (50%), head and neck area (25%), or extremities (25%). Th is pathophysiology results from an identifi ed collagen type III gene mutation (substitution of glycine) known as COL3A1 that results in decreased thermal stability and proteolytic processing in the proA1 chain of collagen type III ( 4 ). Th ese defects lead to devastating complications, including vascular dissection (aneurysmal formation, arteriovenous fi stulae, or dissection), gastrointestinal perforation, or uterine rupture ( 4 ). Common childhood occurrences in those aff ected by vascular-type EDS may include talipes equinovarus, inguinal hernia, pneumothorax, and recurrent joint subluxation or dislocation ( 4 ) . Cerebrovascular complications may also occur, including intracranial hemorrhage due to carotid cavernous sinus fi stulae or cervical artery aneurysmal rupture ( 4 ). Historically, 25% of those with genetic testing confi rming vascular-type EDS experience a signifi cant medical problem requiring hospitalization by age 20 (∼75% by age 40), and the median life expectancy for those with vascular-type EDS is 48 years ( 4 ) .
Sequence analysis of COL3A1 confi rms the clinical diagnosis of vascular-type EDS in over 95% of the cases. Most mutations are point (missense or skipping) mutations that lead to substitutions for glycine (substitution of glycine by glutamic acid driven by a mutation in exon 46 COL3A1 ) in the triple helical region of the collagen molecule. Other types of mutations have also been identifi ed, such as splice site mutations, partial gene deletions, and rarely tested mutations resulting in COL3A1 haploinsuffi ciency ( 5 ) . Th e types of mutations are thought to be relevant since missense and exon-skipping mutations of COL3A1 seem to be associated with a higher risk of vascular or organ rupture prior to the age of 23 years. Alternatively, individuals with haploinsuffi ciency mutations tend to have a lower risk of vascular or organ rupture, with major complications occurring before the age of 37 years ( 5 ) . For these reasons, haploinsuffi ciency mutations have become of increasing interest, and some postulate that presentations of vascular-type EDS at older ages is a result of this type of mutation.
Characteristics associated with the two patients are listed in the Table . While Patient 1 had confi rmed genetic testing and fi t a number of major/minor criteria, Patient 2 was older and had a number of vascular fi ndings (aneurysms, pseudoaneurysms, hernias, cerebrovascular events) that are suggestive of EDS type 4. Although genetic testing could not be confi rmed, patients presenting at older ages with milder forms of disease have been noted due to haploinsuffi ciency mutations that are not commonly tested for.
Despite these diff erences, recognizing basic variations in presentations will allow clinicians to consider a diagnosis of EDS type 4. Although it is a rare disease, the inability to recognize the pertinent medical history, key physical fi ndings, and potential risks of elective procedures in this population may have devastating consequences. Being familiar with these domains is paramount to delivering optimal treatment and avoiding undesirable outcomes. 
